In silico prediction of cancer immunogens: current state of the art.

Related Articles

In silico prediction of cancer immunogens: current state of the art.

BMC Immunol. 2018 Mar 15;19(1):11

Authors: Doytchinova IA, Flower DR

Abstract
Cancer kills 8 million annually worldwide. Although survival rates in prevalent cancers continue to increase, many cancers have no effective treatment, prompting the search for new and improved protocols. Immunotherapy is a new and exciting addition to the anti-cancer arsenal. The successful and accurate identification of aberrant host proteins acting as antigens for vaccination and immunotherapy is a key aspiration for both experimental and computational research. Here we describe key elements of in silico prediction, including databases of cancer antigens and bleeding-edge methodology for their prediction. We also highlight the role dendritic cell vaccines can play and how they can act as delivery mechanisms for epitope ensemble vaccines. Immunoinformatics can help streamline the discovery and utility of Cancer Immunogens.

PMID: 29544447 [PubMed - in process]

http://ift.tt/2HKIom8